These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Mechanism of Interferon-Stimulated Gene Induction in HIV-1-Infected Macrophages. Nasr N; Alshehri AA; Wright TK; Shahid M; Heiner BM; Harman AN; Botting RA; Helbig KJ; Beard MR; Suzuki K; Kelleher AD; Hertzog P; Cunningham AL J Virol; 2017 Oct; 91(20):. PubMed ID: 28768867 [TBL] [Abstract][Full Text] [Related]
27. Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy. Tsai A; Irrinki A; Kaur J; Cihlar T; Kukolj G; Sloan DD; Murry JP J Virol; 2017 Apr; 91(8):. PubMed ID: 28179531 [TBL] [Abstract][Full Text] [Related]
28. Studies on toll-like receptor stimuli responsiveness in HIV-1 and HIV-2 infections. Nowroozalizadeh S; Månsson F; da Silva Z; Repits J; Dabo B; Pereira C; Biague A; Albert J; Nielsen J; Aaby P; Fenyö EM; Norrgren H; Holmgren B; Jansson M Cytokine; 2009 Jun; 46(3):325-31. PubMed ID: 19375940 [TBL] [Abstract][Full Text] [Related]
29. Impaired monocyte maturation in response to CpG oligodeoxynucleotide is related to viral RNA levels in human immunodeficiency virus disease and is at least partially mediated by deficiencies in alpha/beta interferon responsiveness and production. Jiang W; Lederman MM; Salkowitz JR; Rodriguez B; Harding CV; Sieg SF J Virol; 2005 Apr; 79(7):4109-19. PubMed ID: 15767412 [TBL] [Abstract][Full Text] [Related]
30. Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients. Monteleone K; Di Maio P; Cacciotti G; Falasca F; Fraulo M; Falciano M; Mezzaroma I; D'Ettorre G; Turriziani O; Scagnolari C Med Microbiol Immunol; 2014 Jun; 203(3):207-16. PubMed ID: 24553842 [TBL] [Abstract][Full Text] [Related]
31. Shift in monocyte apoptosis with increasing viral load and change in apoptosis-related ISG/Bcl2 family gene expression in chronically HIV-1-infected subjects. Patro SC; Pal S; Bi Y; Lynn K; Mounzer KC; Kostman JR; Davuluri RV; Montaner LJ J Virol; 2015 Jan; 89(1):799-810. PubMed ID: 25355877 [TBL] [Abstract][Full Text] [Related]
32. HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production. Harman AN; Lai J; Turville S; Samarajiwa S; Gray L; Marsden V; Mercier SK; Jones K; Nasr N; Rustagi A; Cumming H; Donaghy H; Mak J; Gale M; Churchill M; Hertzog P; Cunningham AL Blood; 2011 Jul; 118(2):298-308. PubMed ID: 21411754 [TBL] [Abstract][Full Text] [Related]
33. Multiple T-cell responses to human immunodeficiency virus type 1 are enhanced by dendritic cells. Huang XL; Fan Z; Borowski L; Rinaldo CR Clin Vaccine Immunol; 2009 Oct; 16(10):1504-16. PubMed ID: 19692626 [TBL] [Abstract][Full Text] [Related]
34. Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat. Olesen R; Vigano S; Rasmussen TA; Søgaard OS; Ouyang Z; Buzon M; Bashirova A; Carrington M; Palmer S; Brinkmann CR; Yu XG; Østergaard L; Tolstrup M; Lichterfeld M J Virol; 2015 Oct; 89(20):10176-89. PubMed ID: 26223643 [TBL] [Abstract][Full Text] [Related]
35. Tetherin does not significantly restrict dendritic cell-mediated HIV-1 transmission and its expression is upregulated by newly synthesized HIV-1 Nef. Coleman CM; Spearman P; Wu L Retrovirology; 2011 Apr; 8():26. PubMed ID: 21504576 [TBL] [Abstract][Full Text] [Related]
36. Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo. Lavender KJ; Gibbert K; Peterson KE; Van Dis E; Francois S; Woods T; Messer RJ; Gawanbacht A; Müller JA; Münch J; Phillips K; Race B; Harper MS; Guo K; Lee EJ; Trilling M; Hengel H; Piehler J; Verheyen J; Wilson CC; Santiago ML; Hasenkrug KJ; Dittmer U J Virol; 2016 Jul; 90(13):6001-6013. PubMed ID: 27099312 [TBL] [Abstract][Full Text] [Related]
37. Genome-wide transcriptional profiling reveals that HIV-1 Vpr differentially regulates interferon-stimulated genes in human monocyte-derived dendritic cells. Zahoor MA; Xue G; Sato H; Aida Y Virus Res; 2015 Oct; 208():156-63. PubMed ID: 26116899 [TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals. Griesbeck M; Valantin MA; Lacombe K; Samri-Hassimi A; Bottero J; Blanc C; Sbihi Z; Zoorob R; Katlama C; Guiguet M; Altfeld M; Autran B; AIDS; 2017 Jun; 31(9):1223-1234. PubMed ID: 28492391 [TBL] [Abstract][Full Text] [Related]
39. Assessment of Key Elements in the Innate Immunity System Among Patients with HIV, HCV, and Coinfections of HIV/HCV. Moradi M; Tabibzadeh A; Javanmard D; Ghorbani S; Bokharaei-Salim F; Keivani H; Khazeni M; Monavari SHR Curr HIV Res; 2020; 18(3):194-200. PubMed ID: 32209045 [TBL] [Abstract][Full Text] [Related]
40. Role for plasmacytoid dendritic cells in anti-HIV innate immunity. Müller-Trutwin M; Hosmalin A Immunol Cell Biol; 2005 Oct; 83(5):578-83. PubMed ID: 16174110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]